FI955786A0 - Användning av naturprodukter och liknande syntetiska föreningar vid behandling av kardiovakulära sjukdomar - Google Patents

Användning av naturprodukter och liknande syntetiska föreningar vid behandling av kardiovakulära sjukdomar

Info

Publication number
FI955786A0
FI955786A0 FI955786A FI955786A FI955786A0 FI 955786 A0 FI955786 A0 FI 955786A0 FI 955786 A FI955786 A FI 955786A FI 955786 A FI955786 A FI 955786A FI 955786 A0 FI955786 A0 FI 955786A0
Authority
FI
Finland
Prior art keywords
treatment
cardiovascular diseases
natural products
synthetic compounds
similar synthetic
Prior art date
Application number
FI955786A
Other languages
English (en)
Finnish (fi)
Other versions
FI955786A (sv
Inventor
Basil Don Roufogalis
Colin Charles Duke
Qian Li
Original Assignee
Univ Sydney
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Sydney filed Critical Univ Sydney
Publication of FI955786A0 publication Critical patent/FI955786A0/sv
Publication of FI955786A publication Critical patent/FI955786A/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C39/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
    • C07C39/12—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic with no unsaturation outside the aromatic rings
    • C07C39/15—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic with no unsaturation outside the aromatic rings with all hydroxy groups on non-condensed rings, e.g. phenylphenol
    • C07C39/16—Bis-(hydroxyphenyl) alkanes; Tris-(hydroxyphenyl)alkanes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A61K31/37—Coumarins, e.g. psoralen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C39/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
    • C07C39/12—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic with no unsaturation outside the aromatic rings
    • C07C39/14—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic with no unsaturation outside the aromatic rings with at least one hydroxy group on a condensed ring system containing two rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C39/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
    • C07C39/12—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic with no unsaturation outside the aromatic rings
    • C07C39/15—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic with no unsaturation outside the aromatic rings with all hydroxy groups on non-condensed rings, e.g. phenylphenol
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/06—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2
    • C07D311/08—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring
    • C07D311/16—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring substituted in position 7

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Emergency Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI955786A 1993-06-03 1995-12-01 Användning av naturprodukter och liknande syntetiska föreningar vid behandling av kardiovakulära sjukdomar FI955786A (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPL918193 1993-06-03
PCT/AU1994/000297 WO1994028886A1 (en) 1993-06-03 1994-06-03 Use of natural products and related synthetic compounds for the treatment of cardiovascular disease

Publications (2)

Publication Number Publication Date
FI955786A0 true FI955786A0 (sv) 1995-12-01
FI955786A FI955786A (sv) 1996-01-29

Family

ID=3776946

Family Applications (1)

Application Number Title Priority Date Filing Date
FI955786A FI955786A (sv) 1993-06-03 1995-12-01 Användning av naturprodukter och liknande syntetiska föreningar vid behandling av kardiovakulära sjukdomar

Country Status (16)

Country Link
US (2) US5741821A (sv)
EP (1) EP0703780A4 (sv)
JP (1) JPH09502163A (sv)
KR (1) KR960702749A (sv)
CN (1) CN1124922A (sv)
BG (1) BG100166A (sv)
BR (1) BR9406747A (sv)
CA (1) CA2164317A1 (sv)
CZ (1) CZ318795A3 (sv)
FI (1) FI955786A (sv)
HU (1) HUT74174A (sv)
NO (1) NO954479L (sv)
PL (1) PL311810A1 (sv)
SI (1) SI9420037A (sv)
SK (1) SK147995A3 (sv)
WO (1) WO1994028886A1 (sv)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6545131B1 (en) 1997-05-19 2003-04-08 The Johns Hopkins University Tissue specific prodrug
WO1998052966A1 (en) 1997-05-19 1998-11-26 The Johns Hopkins University School Of Medecine Tissue specific prodrug
US6504014B1 (en) 1997-05-19 2003-01-07 The John Hopkins University Tissue specific prodrug
US6538022B1 (en) 1997-09-24 2003-03-25 Orion Corporation Compounds for deactivating phospholamban function on Ca-ATPase (phopholamban inhibitors)
RU2137472C1 (ru) 1998-10-12 1999-09-20 Тихоокеанский институт биоорганической химии Дальневосточного отделения РАН Лекарственный препарат "гистохром" для лечения острого инфаркта миокарда и ишемической болезни сердца
US6566560B2 (en) 1999-03-22 2003-05-20 Immugen Pharmaceuticals, Inc. Resorcinolic compounds
EP1171628A2 (en) * 1999-04-15 2002-01-16 Devgen NV Compound screening methods
US7053042B1 (en) 1999-07-29 2006-05-30 Samuel Denmeade Activation of peptide prodrugs by hK2
WO2002026728A2 (en) * 2000-09-28 2002-04-04 Immugen Pharmaceuticals, Inc. Antiviral methods and compounds
WO2002026224A2 (en) * 2000-09-28 2002-04-04 Immugen Pharmaceuticals, Inc. Methods and compounds for inhibiting eicosanoid metabolism and platelet aggregation
EP1206934A1 (en) * 2000-11-15 2002-05-22 B. Braun Melsungen Ag Blockade of sodium channels by phenol derivatives
KR100704299B1 (ko) * 2005-11-17 2007-04-09 한국생명공학연구원 신규한 퀴놀린계 화합물, 및 지네 추출물 또는 이로부터 분리된 화합물을 포함하는 심장순환계 질환의 예방 및 치료용 조성물
US9024273B2 (en) * 2010-04-20 2015-05-05 Varian Semiconductor Equipment Associates, Inc. Method to generate molecular ions from ions with a smaller atomic mass

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2321620A (en) * 1940-10-10 1943-06-15 Du Pont Phenolic compounds
DE3527862A1 (de) * 1985-08-02 1987-02-05 Bayer Ag Verfahren zur herstellung von bis-hydroxyphenyl-n-alkanen, neue bis-hydroxyphenyl-n-alkane und neue alkandione

Also Published As

Publication number Publication date
CN1124922A (zh) 1996-06-19
NO954479L (no) 1996-02-02
KR960702749A (ko) 1996-05-23
US5859067A (en) 1999-01-12
BR9406747A (pt) 1996-04-02
SI9420037A (en) 1996-08-31
HUT74174A (en) 1996-11-28
CZ318795A3 (en) 1996-06-12
HU9503441D0 (en) 1996-01-29
NO954479D0 (no) 1995-11-08
PL311810A1 (en) 1996-03-18
BG100166A (en) 1996-11-29
US5741821A (en) 1998-04-21
EP0703780A1 (en) 1996-04-03
JPH09502163A (ja) 1997-03-04
SK147995A3 (en) 1997-04-09
CA2164317A1 (en) 1994-12-22
FI955786A (sv) 1996-01-29
WO1994028886A1 (en) 1994-12-22
EP0703780A4 (en) 1998-01-07

Similar Documents

Publication Publication Date Title
FI942993A (sv) Organo-aluminoxyprodukt och användning av densamma
FI946050A0 (fi) Vaermeisolerande pappersbehaollare och foerfarande foer framstaellning av den
EP0469921A3 (en) Deodorant and product in which the deodorant is used
FI970214A (sv) Användning av droloxifen vid behandling av kardiovaskulära sjukdomar
FI964912A0 (sv) Förbättringar i och vid tillverkning av livsmedelsprodukter
DE69226183D1 (de) Mit fluessigkeiten behandelte polytetrafluroaethylenprodukte und ihre herstellung
FI964911A (sv) Förbättringar i och vid tillverkning av livsmedelsprodukter
FI952656A0 (fi) Foerfarande och anordning vid pulsmaetning av en person
AU3959193A (en) Heterocyclic compounds and their use in the treatment of type II-diabetes
FI955786A (sv) Användning av naturprodukter och liknande syntetiska föreningar vid behandling av kardiovakulära sjukdomar
FI972235A0 (sv) Förfarande för användning av triaryletylenderivat vid behandling och förhindrande av osteoporos
FI941345A (sv) Retinoider och användning av dem vid behandling av hudsjukdomar och leukemi
EP0453658A3 (en) Use of substituted anilides and sulfonamides in the treatment of cardiovascular diseases
FI934950A0 (fi) Anvaendning av furankarboxamider vid skyddande av material
NO962503D0 (no) Anvendelse av penoksyfyllin ved behandling av multippel sklerose
NO922340D0 (no) Fr, og fremgangsmaate for aa optimalisere effekten av pigmenter i for for salmonider
NO942686D0 (no) Anvendelse av 3-arylindol- og 3-arylindazolderivater ved behandling av psykoser
FI972637A (sv) Användning av K-gruppens vitamin vid behandling av hyperparatyreoidism
FI942139A0 (sv) Mellanprodukter användbara vid framställning av pyranylcyanguanidinderivat och förfarande för framställning av dessa
FI932237A0 (fi) Foerfarande vid reglering av belastning av en boejningsreglerbar vals och en boejningsreglerbar vals
LV5035A3 (lv) Preparats govju endometritu profilaksei un arstesanai
FI935454A0 (fi) Glimmer-fosfatprodukt och framstaellning av densamma
FI961908A0 (fi) Anvaendningen av cysteinproteinaser och deras inhibitorer i munhygienprodukter
FI954912A (sv) Användning av ceruletid-ditylaminsalt vid behandling av psoriasis
SE9301098D0 (sv) Ny anvaendning av 17 beta-n-substituerade-4-aza-5 alfa-androstenoner vid framstaellning av ett laekemedel